英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
028547查看　028547　在百度字典中的解释百度英翻中〔查看〕
028547查看　028547　在Google字典中的解释Google英翻中〔查看〕
028547查看　028547　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Tempus | AI-Powered Precision Medicine Genomic Testing
    Tempus has built the world’s largest library of clinical molecular data and an operating system to make that data accessible and useful, starting with cancer
  • Oncology Providers - Tempus
    Empowering precision oncology with AI-driven insights Tempus is a healthcare technology company advancing the use of AI in precision oncology By integrating comprehensive molecular and clinical data, we deliver actionable insights that help oncologists make more informed decisions throughout the patient journey
  • News Releases - Tempus AI
    The Investor Relations website contains information about Tempus AI's business for stockholders, potential investors, and financial analysts
  • Investor Relations | Tempus AI
    The Investor Relations website contains information about Tempus AI's business for stockholders, potential investors, and financial analysts
  • News - Tempus
    Tempus AI, Inc (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the next-generation of Lens, its pioneering agentic AI platform designed to accelerate drug development and research
  • About us | Tempus
    Tempus AI One intelligent platform to help guide clinical decisions Securely access patient information across desktop, mobile, and your EHR Easily place orders, track progress, and review summarized results and automatic therapy updates Quickly unlock insights with our AI-enabled clinical assistant
  • Contact Us - Tempus
    Contact Tempus for support Find contact information for our provider, patient, life sciences, and media relations teams, or submit a general inquiry
  • Our Team - Tempus
    Eric Lefkofsky is the founder and Chief Executive Officer at Tempus, a leader in artificial intelligence and precision medicine He is the co-founder and General Partner of Lightbank, a private venture capital firm specializing in investments in technology companies He is also the co-founder of Pathos AI, a clinical stage biotechnology company focused on re-engineering drug development
  • Tempus Announces Strategic Collaboration Agreement with Merck to . . .
    Tempus AI, Inc (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Merck, known as MSD outside of the United States and Canada, today announced an expanded, multi-year collaboration aimed at accelerating the discovery and development of precision medicine biomarkers and supporting Merck’s oncology and potentially broader therapeutic portfolios
  • Tempus Announces Pricing of Initial Public Offering
    Tempus AI, Inc (“Tempus”) today announced the pricing of its initial public offering of 11,100,000 shares of its Class A common stock at a public offering price of $37 00 per share All of the shares of Class A common stock are being offered by Tempus The gross proceeds to Tempus from the offering, before deducting underwriting discounts and commissions and other offering expenses





中文字典-英文字典  2005-2009